100 related articles for article (PubMed ID: 30550094)
1. [The study of patterns of development of resistance of Staphylococcus aureus to triclosan].
Detusheva EV; Skryiabin YP; Bogun AG; Kislichkina AA; Kadnikova LA; Fursova NK
Klin Lab Diagn; 2018; 63(1):60-64. PubMed ID: 30550094
[TBL] [Abstract][Full Text] [Related]
2. Mutations upstream of fabI in triclosan resistant Staphylococcus aureus strains are associated with elevated fabI gene expression.
Grandgirard D; Furi L; Ciusa ML; Baldassarri L; Knight DR; Morrissey I; Largiadèr CR; Leib SL; Oggioni MR
BMC Genomics; 2015 Apr; 16(1):345. PubMed ID: 25924916
[TBL] [Abstract][Full Text] [Related]
3. Defining and combating the mechanisms of triclosan resistance in clinical isolates of Staphylococcus aureus.
Fan F; Yan K; Wallis NG; Reed S; Moore TD; Rittenhouse SF; DeWolf WE; Huang J; McDevitt D; Miller WH; Seefeld MA; Newlander KA; Jakas DR; Head MS; Payne DJ
Antimicrob Agents Chemother; 2002 Nov; 46(11):3343-7. PubMed ID: 12384334
[TBL] [Abstract][Full Text] [Related]
4. A novel resistance mechanism to triclosan that suggests horizontal gene transfer and demonstrates a potential selective pressure for reduced biocide susceptibility in clinical strains of Staphylococcus aureus.
Ciusa ML; Furi L; Knight D; Decorosi F; Fondi M; Raggi C; Coelho JR; Aragones L; Moce L; Visa P; Freitas AT; Baldassarri L; Fani R; Viti C; Orefici G; Martinez JL; Morrissey I; Oggioni MR;
Int J Antimicrob Agents; 2012 Sep; 40(3):210-20. PubMed ID: 22789727
[TBL] [Abstract][Full Text] [Related]
5. Biochemical and genetic characterization of the action of triclosan on Staphylococcus aureus.
Slater-Radosti C; Van Aller G; Greenwood R; Nicholas R; Keller PM; DeWolf WE; Fan F; Payne DJ; Jaworski DD
J Antimicrob Chemother; 2001 Jul; 48(1):1-6. PubMed ID: 11418506
[TBL] [Abstract][Full Text] [Related]
6. Triclosan and antibiotic resistance in Staphylococcus aureus.
Suller MT; Russell AD
J Antimicrob Chemother; 2000 Jul; 46(1):11-8. PubMed ID: 10882683
[TBL] [Abstract][Full Text] [Related]
7. Triclosan resistance in methicillin-resistant Staphylococcus aureus (MRSA).
Brenwald NP; Fraise AP
J Hosp Infect; 2003 Oct; 55(2):141-4. PubMed ID: 14529640
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene.
Heath RJ; Li J; Roland GE; Rock CO
J Biol Chem; 2000 Feb; 275(7):4654-9. PubMed ID: 10671494
[TBL] [Abstract][Full Text] [Related]
9. A triclosan-ciprofloxacin cross-resistant mutant strain of Staphylococcus aureus displays an alteration in the expression of several cell membrane structural and functional genes.
Tkachenko O; Shepard J; Aris VM; Joy A; Bello A; Londono I; Marku J; Soteropoulos P; Peteroy-Kelly MA
Res Microbiol; 2007; 158(8-9):651-8. PubMed ID: 17997080
[TBL] [Abstract][Full Text] [Related]
10. STUDY OF ANTIBACTERIAL ACTIVITY OF THE PREPARATIONS WITH DIOXIDINE AND LEVOFLOXACIN ON MAIN PURULENT-INFLAMMATORY PROCESSES PATHOGENS.
Shtaniuk EA; Vovk OO; Krasnikova LV; Polyvianna YI; Kovalenko TI
Wiad Lek; 2021; 74(9 cz 1):2109-2111. PubMed ID: 34725285
[TBL] [Abstract][Full Text] [Related]
11. Discovery of 4-Pyridone derivatives as specific inhibitors of enoyl-acyl carrier protein reductase (FabI) with antibacterial activity against Staphylococcus aureus.
Takahata S; Iida M; Yoshida T; Kumura K; Kitagawa H; Hoshiko S
J Antibiot (Tokyo); 2007 Feb; 60(2):123-8. PubMed ID: 17420562
[TBL] [Abstract][Full Text] [Related]
12. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
13. Fatty Acid Supplementation Reverses the Small Colony Variant Phenotype in Triclosan-Adapted Staphylococcus aureus: Genetic, Proteomic and Phenotypic Analyses.
Bazaid AS; Forbes S; Humphreys GJ; Ledder RG; O'Cualain R; McBain AJ
Sci Rep; 2018 Mar; 8(1):3876. PubMed ID: 29497096
[TBL] [Abstract][Full Text] [Related]
14. Small-colony variants: a novel mechanism for triclosan resistance in methicillin-resistant Staphylococcus aureus.
Seaman PF; Ochs D; Day MJ
J Antimicrob Chemother; 2007 Jan; 59(1):43-50. PubMed ID: 17079243
[TBL] [Abstract][Full Text] [Related]
15. Staphylococcus aureus but not Listeria monocytogenes adapt to triclosan and adaptation correlates with increased fabI expression and agr deficiency.
Nielsen LN; Larsen MH; Skovgaard S; Kastbjerg V; Westh H; Gram L; Ingmer H
BMC Microbiol; 2013 Jul; 13():177. PubMed ID: 23898801
[TBL] [Abstract][Full Text] [Related]
16. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
17. An Efficient and Economical Assay to Screen for Triclosan Binding to FabI.
Demissie RD; Kabre P; Tuntland ML; Fung LW
J Biomol Screen; 2016 Apr; 21(4):391-8. PubMed ID: 26538431
[TBL] [Abstract][Full Text] [Related]
18. Whither triclosan?
Russell AD
J Antimicrob Chemother; 2004 May; 53(5):693-5. PubMed ID: 15073159
[TBL] [Abstract][Full Text] [Related]
19. Nonactive-Site Mutations in
Demissie R; Kabre P; Fung LW
ACS Omega; 2020 Sep; 5(36):23175-23183. PubMed ID: 32954168
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into Staphylococcus aureus enoyl-ACP reductase (FabI), in complex with NADP and triclosan.
Priyadarshi A; Kim EE; Hwang KY
Proteins; 2010 Feb; 78(2):480-6. PubMed ID: 19768684
[No Abstract] [Full Text] [Related]
[Next] [New Search]
